Senior insider sale
Chief Medical Officer at DENALI THERAPEUTICS INC. — senior position signals high conviction
$284.1K
17.22K shares
What this filing means
HO CAROLE plans to sell 17.22K shares of DENALI THERAPEUTICS INC. valued at approximately $284.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/6/2026ACC: 0001724605-26-000004
Officer· Chief Medical Officer
Since Aug 2018
17.22K
Shares to sell
$284.1K
Approx. market value
17.22K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Lapse - See Remarks
Equity Compensation
1/3/2026
17.22KTotal acquired17.22K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/3/2026 | Restricted Stock Lapse - See Remarks Equity Compensation | 17.22K | — |
| Total | 17.22K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
17.22K
Market value
$284.1K
1/6/2026
Total
Units
17.22K
Value
$284.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/6/2026 | 17.22K | $284.1K | NASDAQ | Planned |
| Total | 17.22K | $284.1K | ||